| EP3717916 - TARGET INTERFERENCE SUPPRESSED ANTI-DRUG ANTIBODY ASSAY [Right-click to bookmark this link] | Status | Unitary effect registered Database last updated on 28.03.2026 | |
| Former | Request for unitary effect filed Status updated on 22.01.2025 | Most recent event Tooltip | 24.10.2025 | New entry: Payment of renewal fee | Proprietor(s) | For all participating member states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | [2025/09] | Inventor(s) | 01 /
DAHL, Uwe c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | 02 /
JORDAN, Gregor c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | 03 /
STAACK, Roland c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | 04 /
MOHEYSEN-ZADEH, Miriam c/o Roche Diagnostics GmbH Nonnenwald 2 82377 Penzberg / DE | [2020/41] | Representative(s) | Skolaut, Alexander Roche Diagnostics GmbH Patentabteilung LPAA....6164 Nonnenwald 2 82377 Penzberg / DE | [2025/09] | Application number, filing date | 18804654.4 | 27.11.2018 | [2020/41] | WO2018EP82664 | Procedural language | EN | (Principal) place of business Tooltip on the date of filing | Principal place of businessTooltip | Unitary Patent Protection | 22.01.2025 | Date of request for unitary effect [2025/09] | 28.01.2025 | Decision on the request for unitary effect: Positive [2025/09] | 28.01.2025 | Date of registration [2025/09] | 01.01.2025 | Date of legal effect [2025/09] | Member States covered by Unitary Tooltip Patent Protection | 28.01.2025 | AT, BE, BG, DE, DK, EE, FI, FR, IT, LT, LU, LV, MT, NL, PT, RO, SE, SI [2025/09] | Publication | Type: | B1 Patent specification | No.: | EP3717916 | Date: | 01.01.2025 | Language: | EN | [2025/01] | Renewal fees paid | Renewal fee | 22.10.2025 | Renewal fee unitary effect year 08 |